Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management): An Assessment of Individual Antiarrhythmic Drug Therapies Compared With Rate Control With Propensity Score-Matched Analyses

Study Questions:

How do individual rhythm-control agents affect cardiovascular outcomes in patients with atrial fibrillation (AF)?